India's vaccine output likely to fall short of target, sources say | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
India's vaccine output likely to fall short of target, sources say

Coronavirus chronicle

Reuters
20 May, 2021, 06:35 pm
Last modified: 20 May, 2021, 06:40 pm

Related News

  • India for 'inclusive, fair, free' polls in Bangladesh at an early date
  • Google begins direct online sales of Pixel phones in India
  • Shrimp fry worth Tk1cr seized in Cumilla while being smuggled to India
  • India's alarm over Chinese spying rocks the surveillance industry
  • 31 more people pushed into Bangladesh through Kurigram, C’Nawabganj borders

India's vaccine output likely to fall short of target, sources say

Lower-than-expected production could delay India's plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter

Reuters
20 May, 2021, 06:35 pm
Last modified: 20 May, 2021, 06:40 pm
FILE PHOTO: A policeman asks people who came to receive a dose of a coronavirus vaccine to leave as they stand outside the gate of a vaccination centre which was closed due to unavailability of the supply of COVID-19 vaccine, in Mumbai, India. REUTERS/Francis Mascarenhas/File Photo
FILE PHOTO: A policeman asks people who came to receive a dose of a coronavirus vaccine to leave as they stand outside the gate of a vaccination centre which was closed due to unavailability of the supply of COVID-19 vaccine, in Mumbai, India. REUTERS/Francis Mascarenhas/File Photo

India's output of Covid-19 shots for August-December is likely to be lower than the government's public estimate, according to internal projections shared with Reuters by two sources.

Lower-than-expected production could delay India's plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter. India's ongoing second wave, the world's worst since the pandemic began, has overwhelmed its health system. read more

The government last week publicly estimated 1.46 billion doses of its three approved shots - AstraZeneca, Sputnik V and Covaxin - would be made between August and December.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Production of the AstraZeneca vaccine, of which the Serum Institute of India (SII) is the biggest maker in the world, is expected to reach 100 million to 110 million doses a month from July and stay at that level for the foreseeable future, a source with knowledge of the matter said.

That would be at least 200 million doses less than the government's public forecast of 750 million AstraZeneca doses for the last five months of the year, a 27% shortfall.

An internal government projection for August and September shared by a second source put the monthly number of AstraZeneca doses at 100 million, out of 200 million for all the three approved shots combined.

The sources declined to be named discussing a subject on which Prime Minister Narendra Modi's government has been criticised due to a shortage of vaccines. Immunisations have fallen sharply since an April peak.

The Ministry of Health and Family Welfare did not respond to queries from Reuters.

SII, which is facing raw material shortages for another vaccine that the government is banking on, declined to comment.

A spokeswoman for Covaxin-maker Bharat Biotech said that last month the company raised its annual production capacity to more than 500 million doses, or about 42 million doses a month. It has been producing about 10 million doses a month.

Dr. Reddy's Laboratories, the local distributor for Russia's Sputnik V, did not respond to a request for comment.

Apart from the approved vaccines, the government has also forecast August-December production of 866 million doses of five yet-to-be-approved vaccines. Overall, the government has pledged to make 2.67 billion doses available this year.

SII has already halted exports until the end of the year to meet domestic demand, in a major blow to dozens of poor countries relying on it for supplies. read more

India has so far administered 187 million vaccine doses, the most after China and the United States, but fully immunised only about 3% of its 1.35 billion people.

World+Biz

India / Covid-19 vaccine production / Covid-19 vaccines / Vaccine Production / Serum Institute of India (SII) / AstraZeneca / Sputnik V / Dr Reddy's Laboratories

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Attackers vandalise the windows of the residence of Jatiyo Party (JaPa) Chairman GM Quader and set fire to a motorcycle in Rangpur on 29 May 2025. Photo: TBS
    Jatiyo Party chief GM Quader's house in Rangpur attacked; SAD activists blamed
  • NBR officers declare chairman persona non grata at headquarters
    NBR officers declare chairman persona non grata at headquarters
  • Ambassador of the European Union (EU) to Bangladesh Michael Miller. File Photo: UNB
    Election date entirely Bangladesh's decision; which parties will join polls also their own decision: EU envoy

MOST VIEWED

  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Md Nazrul Islam Swapan, chairman of EXIM Bank. Sketch: TBS
    Exim Bank restored depositors’ confidence, overcoming challenges
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • India for 'inclusive, fair, free' polls in Bangladesh at an early date
  • Google begins direct online sales of Pixel phones in India
  • Shrimp fry worth Tk1cr seized in Cumilla while being smuggled to India
  • India's alarm over Chinese spying rocks the surveillance industry
  • 31 more people pushed into Bangladesh through Kurigram, C’Nawabganj borders

Features

For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

4h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

4h | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

4h | Panorama
Stillbirths in Bangladesh: A preventable public health emergency

Stillbirths in Bangladesh: A preventable public health emergency

4h | Panorama

More Videos from TBS

Record migrant deaths in 2024

Record migrant deaths in 2024

1h | Podcast
News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

3h | TBS News of the day
Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

6h | TBS Insight
Love is essential for human life

Love is essential for human life

5h | TBS Programs
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net